Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Cancer Science|July 27, 2017
Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinomaTakayuki Arai, Atsushi Okato, Satoko Kojima, et al.
International Journal of Oncology|December 12, 2018
Molecular pathogenesis of esophageal squamous cell carcinoma: Identification of the antitumor effects of miR‑145‑3p on gene regulationMasataka Shimonosono, Tetsuya Idichi, Naohiko Seki, et al.
Oncotarget|July 11, 2018
Involvement of anti-tumor miR-124-3p and its targets in the pathogenesis of pancreatic ductal adenocarcinoma: direct regulation of ITGA3 and ITGB1 by miR-124-3pTetsuya Idichi, Naohiko Seki, Hiroshi Kurahara, et al.
Pancreas|May 14, 2024
Genetic Assessment of Intraductal Papillary Mucinous Neoplasm for Predicting Concomitant Pancreatic Ductal AdenocarcinomaHideyuki Oi, Yuto Hozaka, Toshiaki Akahane, et al.
Cancer Science|April 17, 2018
Molecular pathogenesis of pancreatic ductal adenocarcinoma: Impact of passenger strand of pre-miR-148a on gene regulationTetsuya Idichi, Naohiko Seki, Hiroshi Kurahara, et al.
Surgical Case Reports|December 17, 2021
Postoperative recurrence with right cervical lymph node metastasis in hepatocellular carcinoma: a case reportKiyonori Tanoue, Yota Kawasaki, Yoichi Yamasaki, et al.
Surgical Case Reports|January 10, 2022
Multidisciplinary treatment of advanced or recurrent solid pseudopapillary neoplasm of the pancreas: three case reportsKiyonori Tanoue, Yuko Mataki, Hiroshi Kurahara, et al.
Journal of Human Genetics|July 6, 2020
RNA sequencing-based microRNA expression signature in esophageal squamous cell carcinoma: oncogenic targets by antitumor miR-143-5p and miR-143-3p regulationMasumi Wada, Yusuke Goto, Takako Tanaka, et al.
Oncotarget|September 9, 2017
Regulation of actin-binding protein ANLN by antitumor miR-217 inhibits cancer cell aggressiveness in pancreatic ductal adenocarcinomaTetsuya Idichi, Naohiko Seki, Hiroshi Kurahara, et al.
Anticancer Research|July 5, 2022
Implications of PD-1, Tim-3, and TIGIT Expression for Cancer Immunity and Pancreatic Cancer PrognosisChieri Nakayama, Kiyonori Tanoue, Tetsuya Idichi, et al.
Pageof 6